Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport

World Journal of Gastroenterology

Volumn 21, Issue 30, 2015, Pages 9055-9066

  Datta, Palika ^a   Weis, Margaret T ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Calcium glycerophosphate; Cytokine; Gliadin peptide; Intestinal ischemia; Intestinal permeability

Indexed keywords

GAMMA INTERFERON; GLIADIN; GLYCEROPHOSPHATE CALCIUM; INTERLEUKIN 1BETA; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; CYTOKINE; GLYCEROPHOSPHATE; MANNITOL;

ARTICLE; CARDIOVASCULAR FUNCTION; CELL LOSS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; HYPOXIA; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; PROTEIN EXPRESSION; TIGHT JUNCTION; TISSUE PRESERVATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; CACO-2 CELL LINE; CELL HYPOXIA; CELL PROTECTION; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; IMPEDANCE; INTESTINE MUCOSA; METABOLISM; PERMEABILITY; TIME FACTOR; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL HYPOXIA; CYTOKINES; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; GLIADIN; GLYCEROPHOSPHATES; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MANNITOL; PERMEABILITY; TIME FACTORS;

EID: 84940208884     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i30.9055     Document Type: Article

References (31)

1. Peters HP, Bos M, Seebregts L, Akkermans LM, van Berge Henegouwen GP, Bol E, Mosterd WL, de Vries WR. Gastrointestinal symptoms in long-distance runners, cyclists, and triathletes: prevalence, medication, and etiology. Am J Gastroenterol 1999; 94: 1570-1581 [PMID: 10364027 DOI: 10.1111/j.1572-0241.1999.01147. x]
2. van Wijck K, Lenaerts K, Grootjans J, Wijnands KA, Poeze M, van Loon LJ, Dejong CH, Buurman WA. Physiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: strategies for evaluation and prevention. Am J Physiol Gastrointest Liver Physiol 2012; 303: G155-G168 [PMID: 22517770 DOI: 10.1152/ajpgi.00066.2012]
3. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007; 50: 1561-1569 [PMID: 17936155 DOI: 10.1016/j.jacc.2007.07.016]
4. Krüger S, Kunz D, Graf J, Stickel T, Merx MW, Koch KC, Janssens U, Hanrath P. Endotoxin hypersensitivity in chronic heart failure. Int J Cardiol 2007; 115: 159-163 [PMID: 16766065 DOI: 10.1016/j.ijcard.2006.03.003]
5. Arvidsson D, Rasmussen I, Almqvist P, Niklasson F, Haglund U. Splanchnic oxygen consumption in septic and hemorrhagic shock. Surgery 1991; 109: 190-197 [PMID: 1899492]
6. Jakob SM. Clinical review: splanchnic ischaemia. Crit Care 2002; 6: 306-312 [PMID: 12225604]
7. Jakob SM, Ruokonen E, Vuolteenaho O, Lampainen E, Takala J. Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med 2001; 29: 1393-1398 [PMID: 11445693]
8. Prior AM, Zhang M, Blakeman N, Datta P, Pham H, Chen Q, Young LH, Weis MT, Hua DH. Inhibition of long chain fatty acyl- CoA synthetase (ACSL) and ischemia reperfusion injury. Bioorg Med Chem Lett 2014; 24: 1057-1061 [PMID: 24480468 DOI: 10.1016/j.bmcl.2014.01.016]
9. Blakeman N, Chen Q, Tolson J, Rueter B, Diaz B, Casey B, Young LH, Weis MT. Triacsin C, a Fatty Acyl CoA Synthetase Inhibitor, Improves Cardiac Performance Following Global Ischemia. Am J Biomed Sci 2012; 4: 249-261
10. Sardjono CT, Harbour SN, Yip JC, Paddock C, Tridandapani S, Newman PJ, Jackson DE. Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection. Thromb Haemost 2006; 96: 756-766 [PMID: 17139370]
11. Sim DS, Dilks JR, Flaumenhaft R. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Arterioscler Thromb Vasc Biol 2007; 27: 1478-1485 [PMID: 17303775 DOI: 10.1161/ATVBAHA.106.139287]
12. Esposito E, Mazzon E, Muià C, Meli R, Sessa E, Cuzzocrea S. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha. J Leukoc Biol 2007; 81: 1032-1043 [PMID: 17210619 DOI: 10.1189/jlb.0706480]
13. Cavriani G, Domingos HV, Oliveira-Filho RM, Sudo-Hayashi LS, Vargaftig BB, de Lima WT. Lymphatic thoracic duct ligation modulates the serum levels of IL-1beta and IL-10 after intestinal ischemia/reperfusion in rats with the involvement of tumor necrosis factor alpha and nitric oxide. Shock 2007; 27: 209-213 [PMID: 17224798 DOI: 10.1097/01.shk.0000238068.84826.52]
14. Xu DZ, Lu Q, Kubicka R, Deitch EA. The effect of hypoxia/reoxygenation on the cellular function of intestinal epithelial cells. J Trauma 1999; 46: 280-285 [PMID: 10029034]
15. Qiu Y, Yu M, Yang Y, Sheng H, Wang W, Sun L, Chen G, Liu Y, Xiao W, Yang H. Disturbance of intraepithelial lymphocytes in a murine model of acute intestinal ischemia/reperfusion. J Mol Histol 2014; 45: 217-227 [PMID: 24122227 DOI: 10.1007/s10735-013-9544-1]
16. Greenspon J, Li R, Xiao L, Rao JN, Sun R, Strauch ED, Shea- Donohue T, Wang JY, Turner DJ. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. Dig Dis Sci 2011; 56: 1342-1353 [PMID: 20936358 DOI: 10.1007/s10620-010-1421-0]
17. Tardivel S, Razanamaniraka L, Porembska Z, Crouzoulon G, Fournier P, Dupuis Y. Homodimer and heterodimer forms of adult rat intestinal alkaline phosphatase. Life Sci 1988; 43: 2059-2065 [PMID: 3210900]
18. Edsall LC, Spiegel S. Enzymatic measurement of sphingosine 1-phosphate. Anal Biochem 1999; 272: 80-86 [PMID: 10405296 DOI: 10.1006/abio.1999.4157]
19. Iacomino G, Fierro O, D'Auria S, Picariello G, Ferranti P, Liguori C, Addeo F, Mamone G. Structural analysis and Caco-2 cell permeability of the celiac-toxic A-gliadin peptide 31-55. J Agric Food Chem 2013; 61: 1088-1096 [PMID: 23298305 DOI: 10.1021/jf3045523]
20. Jumarie C, Malo C. Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro. J Cell Physiol 1991; 149: 24-33 [PMID: 1939345 DOI: 10.1002/jcp.1041490105]
21. Caputo I, Secondo A, Lepretti M, Paolella G, Auricchio S, Barone MV, Esposito C. Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells. PLoS One 2012; 7: e45209 [PMID: 23049776 DOI: 10.1371/journal.pone.0045209]
22. Rauhavirta T, Oittinen M, Kivistö R, Männistö PT, Garcia- Horsman JA, Wang Z, Griffin M, Mäki M, Kaukinen K, Lindfors K. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study. J Clin Immunol 2013; 33: 134-142 [PMID: 22878839 DOI: 10.1007/s10875-012-9745-5]
23. Yang T, Roder KE, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. Protein kinase C family members as a target for regulation of blood-brain barrier Na,K,2Cl-cotransporter during in vitro stroke conditions and nicotine exposure. Pharm Res 2006; 23: 291-302 [PMID: 16450214 DOI: 10.1007/s11095-005-9143-2]
24. Anker SD, Volterrani M, Egerer KR, Felton CV, Kox WJ, Poole- Wilson PA, Coats AJ. Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure. QJM 1998; 91: 199-203 [PMID: 9604072]
25. Larsen J, Dall M, Antvorskov JC, Weile C, Engkilde K, Josefsen K, Buschard K. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol 2014; 44: 3056-3067 [PMID: 25043259 DOI: 10.1002/eji.201344264]
26. Sandek A, Valentova M, von Haehling S, Doehner W, Anker SD. The small intestine: a critical linkage in pathophysiology of cardiac cachexia. Int J Cardiol 2011; 146: 277-278 [PMID: 21112652 DOI: 10.1016/j.ijcard.2010.10.083]
27. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Executive summary: heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014; 129: 399-410 [PMID: 24446411 DOI: 10.1161/01. cir.0000442015.53336.12]
28. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361: 1077-1083 [PMID: 12672310 DOI: 10.1016/S0140-6736(03)12892-9]
29. Van Wijck K, Lenaerts K, Van Bijnen AA, Boonen B, Van Loon LJ, Dejong CH, Buurman WA. Aggravation of exercise-induced intestinal injury by Ibuprofen in athletes. Med Sci Sports Exerc 2012; 44: 2257-2262 [PMID: 22776871 DOI: 10.1249/MSS.0b013e318265dd3d]
30. van Wijck K, Wijnands KA, Meesters DM, Boonen B, van Loon LJ, Buurman WA, Dejong CH, Lenaerts K, Poeze M. L-citrulline improves splanchnic perfusion and reduces gut injury during exercise. Med Sci Sports Exerc 2014; 46: 2039-2046 [PMID: 24621960 DOI: 10.1249/MSS.0000000000000332]
31. Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg 2011; 17: 36-39 [PMID: 22453670 DOI: 10.1097/SPV.0b013e3182044b5c]